home / stock / scps / scps news


SCPS News and Press, Scopus BioPharma Inc. From 08/25/21

Stock Information

Company Name: Scopus BioPharma Inc.
Stock Symbol: SCPS
Market: NASDAQ
Website: scopusbiopharma.com

Menu

SCPS SCPS Quote SCPS Short SCPS News SCPS Articles SCPS Message Board
Get SCPS Alerts

News, Short Squeeze, Breakout and More Instantly...

SCPS - 5 Best Penny Stocks To Buy Right Now According To Insiders

Penny Stocks Insiders Are Scooping Up Is there a secret to finding the best penny stocks to buy right now? If you ask some traders, they’ll tell you to follow the money. But what does that actually mean? This entails following big trades made in the market & that goes for bot...

SCPS - BioNTech, Robinhood Markets, Roku among premarket losers' pack

Fastly FSLY -23% on Q2 earnings release  Karyopharm Therapeutics KPTI -18% on Q2 earnings release  Fiverr International FVRR -17% on Q2 earnings release Etsy ETSY -13% on Q2 earnings release Maxar Technologies MAXR -13% on Q2 earning...

SCPS - Shares of Scopus BioPharma Inc. (SCPS) Fall to a New 52-Week Low

Shares of Scopus BioPharma Inc. (NASDAQ:SCPS) traded at a new 52-week low today of $4.87. So far today approximately 5.2 million shares have been exchanged, as compared to an average 30-day volume of 150,000 shares. In the past 52 weeks, Scopus BioPharma Inc. share prices are bracketed b...

SCPS - Scopus Bio names Dr. Alan Horsager as President following acquisition of immunotherapy firm

Scopus BioPharma (SCPS) announces a new appointment following acquisition of immunotherapy company, Olimmune.Alan Horsager, Ph.D., President and CEO of Olimmune, was appointed President of Scopus with responsibility for overseeing the development of the Company’s immuno-oncology p...

SCPS - Scopus BioPharma Announces New Management Appointment Following Acquisition of Leading Immunotherapy Company

NEW YORK, July 12, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) , a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical needs, today announced a new management appo...

SCPS - Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune

Transaction Creates Global Leader in Oligonucleotide Cancer Therapeutics Combined Assets Target Broad Range of Hematological Malignancies and Solid Tumors NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-s...

SCPS - Scopus BioPharma Announces New Date for 2021 Annual Meeting of Stockholders

NEW YORK, May 31, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced that the board of directors has rescheduled the company’s 2021 Annual Meeting of Stockholders (“2021 Annual Meeting”), which will be held on Octob...

SCPS - Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders

NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced it will be rescheduling the company’s 2021 Annual Meeting of Shareholders (the “2021 Annual Meeting”), which was previously scheduled for July 16,...

SCPS - ASXC, SOL, LPCN and ABCL among midday movers

Gainers: Owens & Minor (OMI) +25%.Express (EXPR) +23%.PDL Community Bancorp (PDLB) +22%.Takung Art (TKAT) +22%.Assertio Holdings (ASRT) +21%.Asensus Surgical (ASXC) +20%.Lizhi (LIZI) +20%.ReneSola (SOL) +19%.Arcimoto (FUV) +18%.Planet Green (PLAG) +16%.Losers: Lar...

SCPS - Asensus Surgical, Nabriva Therapeutics leads healthcare gainers; Larimar Therapeutics, Travere Therapeutics among major losers

Gainers: Asensus Surgical ASXC +37%, Nabriva Therapeutics (NBRV) +29%, Kintara Therapeutics KTRA +26%, Owens & Minor (OMI) +21%, Protagenic Therapeutics (PTIX) +10%.Losers: Larimar Therapeutics LRMR -37%, Travere Therapeutics TVTX ...

Previous 10 Next 10